Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
This comprehensive resource covers product change evaluation, postmarket surveillance, audit/inspection compliance, and various other laws and regulations pertaining to maintaining a product on the market.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 06 September 2012 | By Louise Zornoza
China's State Food and Drug Administration (SFDA) has issued guidance to provincial and municipal food and drug agencies and the Chinese Institute of Food and Drug Testing concerning the implementation of goals contained within China's national 12th Five Year Plan.
The plan calls for accelerating "rapid drug testing technology research" to detect counterfeit and adulterated drug products.
The guidance explains SFDA will be responsible for organizing a national system to carry out systematic, targeted research and development of drug testing technology such as reagents, rapid test kits, rapid detection test equipment and other needed technology products.
It will then be the responsibility of all local authorities to use the developed drug testing technology on all drugs, whether domestically produced or imported, SFDA says in the guidance. The end goal of the plan will be to strengthen the regulatory capacity of local agencies to conduct rapid inspection of drug products
SFDA - State Food and Drug Administration Rapid Drug testing technology to accelerate the research and application of guidance on the issuance of the notice (Han Chinese)
Read all Breaking News from RegLink
Tags: 12th Fifth Year Plan, Counterfeit Medicines, SFDA, Latest News, testing